A B S T R A C T Triglyceride metabolism was investigated in groups of fed and fasted rats after 21 days of parenteral estradiol (5 gg daily), progesterone (5 mg daily), or the two steroids in combination. Results were compared with control groups receiving an oil solvent alone. In rats given estradiol separately or combined with progesterone, hypertriglyceridemia was uniformly associated with increased plasma triglyceride entry, estimated with the i.v. Triton WR1339 technique. Progesterone alone had no effect on these parameters.
INTRODUCTION
Estrogens induce elevated plasma triglycerides (1, 2) and undoubtedly have a role in the development of Presented in part at the 46th Annual Meeting of the Central Society for Clinical Research, 2 November 1973, Chicago, Ill.
Received for publication 12 August 1974 and in revised form 2 May 1975. hyperlipemia observed during advancing pregnancy or after the administration of oral contraceptive agents (3, 4) . However, some progestins lower plasma triglycerides and have been utilized in the treatment of certain lipid disorders (5) .
The means by which these steroid hormones influence triglyceride metabolism are not well defined. Estrogeninduced hyperlipemia was thought to reside in impaired peripheral tissue removal of triglyceride, a conclusion based on the suppressive effects of natural and synthetic estrogens on plasma postheparin lipolytic activity, PHLA (6, 7) .' More recent studies suggest that peripheral removal is actually normal in these instances (8, 9) . Although the lowering of serum triglyceride by progestin treatment correlates with increased PHLA (5), more precise events responsible for these effects are also unknown.
Other in vitro investigations that have focused attention on hepatic synthesis and release of lipid into the circulation also do not resolve the problem. After estrogen treatment, precursor incorporation into hepatic triglycerides has been shown to be normal (10) , decreased (11) , or increased (12) . Oral contraceptive agents and other combinations of estrogen and progesterone appear to increase hepatic turnover of this lipid (13, 14) .
In the present study female virgin rats were exposed to physiologic doses of estradiol and progesterone singly or in combination, for 21 days, a normal rat gestation period. Effects of these regimens on triglyceride entry were compared to their action on plasma PHLA, adipose, mammary gland, and protamine-resistant lipoprotein lipase (LPL). These data, in turn, were correlated with alterations of other plasma substrates and insulin concentrations.
The results of our investigation suggest that triglyceride entry into the plasma compartment is an important determinant of plasma triglyceride alterations after sex steroid administration.
'Abbreviations used in this paper: PHLA, postheparin lipolytic activity; LPL, lipoprotein lipase; TG, triglyceride; E, estradiol; P, progesterone; E+P, estradiol plus progesterone; apo-VLDL, apo-very low density lipoprotein. ters with controlled temperature (240C) and light (6 a.m.-6 p.m.). Animals were subdivided into four groups. Control rats received intramuscular sesame oil alone for 21 days. A second group received estradiol benzoate (E) in oil, 5 ,ug daily for the same period. The third group was given progesterone (P) in oil, 5 mg daily for 21 days. The fourth group was on a combined regimen (E+P), 5 Ag and 5 mg of the two hormones, respectively, during the 3-wk period. One-half of the total dose was injected twice daily; injection sites were rotated and volumes of injection did not exceed 0.2 ml.
On the 22nd day, certain groups were studied after 2 h of fasting (hereafter, considered the "fed" animals). Other groups were studied after a 12-h fast. Water was not withheld.
Triglyceride entry studies and measuiremzentts of plasma Triton. Triglyceride entry into the plasma compartment was estimated according to an established method (15 Residues on filter paper were washed three times with 50 ml cold acetone and three times with 50 ml of anhydrous diethyl ether (18) . Residues were then placed in a desiccator jar and traces of ether removed by vacuum suction. Dried residues were stored at 4°C in zvacuo, and lipase activity was measured within 2 wk. With this method of storage some loss of enzyme activity (up to 10%) is unavoidable.
For this reason representative residue from control and treated rats stored for identical durations were always assayed together on the same day.
Mammary gland homogenates obtained from the Waring blendor were treated in a similar fashion (19, 20) except that filtering was done with cheesecloth before subsequent filtering with Whatman no. 5 paper. Milk was not removed from glandular tissue.
Preparation of tissue extracts for LPL assay. Tissue powder was homogenized in 0.05 M NH40H-NH4Cl buffer, pH 8.4 containing 1 IU of heparin/ml. Known weights of adipose tissue powder (5 mg/ml) or mammary gland powder (10 mg/ml) were homogenized with a motor-driven Teflon pestle inserted into a Potter-Elvehjem glass homogenizer at 4VC for 2 min.
After standing 60 min in the cold, homogenates were centrifuged for 10 min at 2,000 rpm at 4°C. Supernates were withdrawn for LPL assay and for measurements of protein content (21) . Additional aliquots of both supernate and precipitate were taken for determinations of DNA (22) . t §11 Significance of the difference between corresponding group means ±SEM: ($) control (C) vs.
other group, P < 0.05; ( §) E vs. P or E + P. P < 0.05; (II) P vs. E + P. P < 0.05.
PHLA and tissue LPL assays. Activated lipid emulsion (0.6 ml) was added to preincubated plasma samples or to 0.2-0.4 ml of mammary gland or adipose tissue extracts (see previous sections). Final volume was adjusted to 1.0 ml with 0.05 M ammonium buffer.
Tubes were placed in a Dubnoff metabolic shaker and incubated for 60 min at 37°C. The reaction was terminated by the addition of 1.0 ml of 10% trichloroacetic acid (wt/ vol). Vigorous mixing was followed by cold centrifugation for 10 min at 2,000 rpm. 1.0-ml supernates containing newly formed [3H]glycerol were mixed with a scintillation liquid and counted (23) . PHLA E alone or in combination with P elevated plasma TG levels, whereas P by itself did not alter this parameter. Regimens containing P promoted a greater weight gain over the 3-wk period in contrast to E alone, which resulted in decreased weight gain in fed rats and normal weight gain in fasted rats as compared to the control group. Fasted animals had lower basal glucose, insulin, and TG concentrations and higher FFA levels than did the fed group (Table I) .
Relationship between Triton dosage and TG increment. At an intravenous dosage of 40 mg Triton/100 g body weight, net plasma increments of Triton at 90 min were not significantly different among the four groups of animals (Table II) (31) . Therefore, the 40-mg/100 g dose of Triton used in this study appeared to be adequate for inducing optimum effects on peripheral TG uptake.
TG entry into plasma. E alone or in combination with P significantly increased the mean increment of plasma TG and TG entry 90 min after Triton injection. (Table II) . Plasmna PHLA. 25 IU of heparin/100 g body weight injected i.v. induced peak PHLA activity within 10 min. This observation was based on a study of 44 rats and measurements of PHLA at several different intervals after heparin administration (Fig. 1) . 4 PHLA in the absence or presence of protamine additions was depressed to the greatest extent by E and was slightly, though significantly diminished by the combined regimen. P had the opposite effect and increased PHLA approximately 11% (Table III) .
Protamine additions had significant inhibitory effects on PHLA, and E or P alone, respectively decreased and increased lipolytic activity relative to control values. However, the combined regimen in this instance was associated with lipolytic activity that was higher than control means unlike that observed in the absence of protamine.5 'This dose of heparin is relatively large. It was chosen, because another laboratory has shown recently that PHLA in plasma of rats treated in this way is more stable during subsequent in vitro preincubations. Lower doses of heparin, however, (10 IU/100 g body weight) induced plasma PHLA that was unstable and substantially reduced in activity during ensuing preincubations (32 (Tables IV, V) . Correlation coefficients relating plasma TG concentrations to TG entry or to lipolytic activity. In fed rats, plasma TG levels related uniformly and most significantly to TG entry. Although inverse correlations were also observed between plasma TG and adipose LPL activity, significance was achieved only in the control group. Relatively poor correlations existed between plasma TG concentrations and plasma PHLA and protamine-resistant PHLA. In the mammary gland, it was of interest that LPL activity tended to parallel concentrations of plasma triglyceride and this was significant after P administration (Table VI) . DISCUSSION E by itself or in combination with P increases plasma TG in fed and fasted rats. P, however, had no significant effect on this parameter. The results are consistent with a number of previous reports of plasma TG alterations after administration of both natural and synthetic estrogens, including those contained in oral contraceptive agents, to animals and human subjects (34) .
Since plasma concentrations of this lipid are determined, in part, by rates of entry into the circulation, this investigation focused attention on an index of this event.
It is well known that liver synthesis and release of TGcontaining lipoproteins accounts for at least 90% of circulating TG in the fasting state (35) . Our results demonstrate a good relationship between elevated plasma TG concentrations and increased TG entry in both fed and fasted rats exposed to E alone or in combination with P. This suggests that an important action of E that is responsible for hypertriglyceridemia is increased hepatic release of this lipid.
Augmented TG entry from liver may relate to several metabolic events. Previous studies from this laboratory that employed a similar animal model have shown increased in vitro incorporation of precursors into hepatic TG in animals exposed to E + P (10). Additional investigations of a variety of animal species treated with higher, less physiologic doses of estrogens, report similar in vitro results in most, but not all instances (11, 12) . More recently, endogenous TG turnover has been shown to be increased in women receiving conventional oral contraceptive agents or synthetic estrogens (13, 14) . These reports collectively suggest that estrogens increase hepatic biosynthesis of TG. It remains to be determined whether this hormone also has selective effects on hepatic carrier apolipoprotein synthesis as re- (II) E vs. P or E + P, P 0.05; ( ¶) P vs. E + P, P < 0.001. Adipose tissue is a rich source of LPL and a major site of TG removal from plasma (37, 38) . E treatment was associated with the greatest elevations of this plasma lipid and was the only situation where increased TG entry and significant suppression of LPL were observed in both adipose tissue and liver (i.e., protamineresistant LPL) as well as in postheparin plasma. In the context of LPL, then, one might conclude that a defective removal mechanism contributed to the plasma lipid disturbance induced by estrogens. Mammary gland tissue responses must be separated from these findings, however, since its LPL activity increased during estrogen treatment, and it is not known to what extent this steroid modifies lipases in other tissues not examined in this study.
Other data do not support a major influence of LPL activity on plasma TGs with other treatment regimens.
In the majority of instances P by itself or combined with E increased tissue LPL activity whereas plasma lipid was either unchanged or increased. Finally, calculations of correlation coefficients which assessed the statistical relationships between plasma TG and plasma PHLA or tissue LPL failed to reveal significance in ( §) control (C) vs. other group P < 0.01; most cases in contrast to a highly significant correlation between plasma levels and TG entry.
The differential effects of sex steroids on plasma PHLA and various tissue LPL activities might be explained in several different ways. First, conventional in vitro measurements of LPL activity are known to be modified by relative concentrations of both inhibitory and stimulatory cofactors derived from apo-VLDL (39) . Some of the discrepancies between activities in plasma and tissues, then, may be caused by uncontrollable differences in levels of these cofactors in the plasma assay system. 6 Differential actions of sex steroids on tissue LPL activities may also relate to indirect effects of estrogen or P on other hormones which may have an influence on specific tissue LPL activities. For example, increased 8In the presence of increasing amounts of serum from rats treated with E or E+P, adipose LPL activities are progressively suppressed (40) . prolactin and growth hormone release or elevated plasma concentrations of free cortisol attend the administration of E (4143), whereas P has suppressive effects on pituitary growth hormone release (44) . Both steroids promote hyperinsulinemia in the rat (45) . Most of these hormonal changes have been shown to influence hormone-sensitive lipases (46) , and it is conceivable that they may also exert effects on LPL activity, since preliminary reports of prolactin-induced alterations of both adipose and mammary gland LPL activity have already appeared (47) , and a similar action of insulin is well established (48) . Our assay system measured glycerol release as an index of LPL activity. It is also possible that accurate determinations of this enzyme may have been obscured by additional effects of these sex steroid regimens on mono-or diglyceride lipases known to be active under these assay conditions (49) (50) (51) . However, actual measurements of these mono-and diglyceride lipases by other techniques (51) in this laboratory revealed that alterations of glycerol release by sex steroids could not be attributed to changes of activity of these enzymes as opposed to LPL (unpublished data).
There has been much emphasis on the role of hyperinsulinemia in the development of hypertriglyceridemia (52) . More recently, actual TG entry in obese states has been related statistically to increased concentrations of plasma insulin (31) . It is also known that plasma substrate alterations including glucose and increased free fatty acid flux to liver may also promote hypertriglyceridemia (53, 54) . In the present study, however, the effects of three different hormonal regimens did not consistently change basal glucose or free fatty acid levels. All treatments did increase plasma concentrations of insulin to a comparable degree despite different effects on TG entry, plasma TG concentrations, and LPL. Moreover, P caused the greatest gains in body weight, attributed by others to increased carcass fat (55) , but this regimen had little effect on plasma TG. These results suggest that the influence of E or P on TG metabolism is more dependent on the actual steroid administered than to changes in plasma glucose, free fatty acids, insulin, or body weight.
We conclude that LPL activities in plasma and certain selected tissues do not correlate uniformly with actual alterations of plasma levels of TG. Others have also reported normal or increased TG removal despite depressed plasma PHLA in women receiving estrogen alone or combined with progestins (14) . Of the two parameters measured in our investigation, LPL and TG entry, the latter appeared to parallel changes in plasma TG most consistently. This also suggests that sex steroid influence on plasma TG may be expressed primarily by their actions on hepatic synthesis and release of this lipid.
